Werbung
Werbung
ANTX
AN2 Therapeutics, Inc. Common Stock
1.30
USDGesponsert
+0.20
+18.64%
08. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
1.33
+0.02
+1.61%
ANTX Ergebnisberichte
Positives Überraschungsverhältnis
ANTX übertreffen die 9 der letzten 15Schätzungen.
60%
Nächster Bericht
Datum des nächsten Berichts
16. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.24
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/-22.58%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/-4.00%
AN2 Therapeutics, Inc. Common Stock earnings per share and revenue
On 12. Nov. 2025, ANTX reported earnings of -0.31 USD per share (EPS) for Q3 25, missing the estimate of -0.22 USD, resulting in a -38.15% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -4.24% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.24 USD, with revenue projected to reach -- USD, implying an decrease of -22.58% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were AN2 Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, AN2 Therapeutics, Inc. Common Stock reported EPS of -$0.31, missing estimates by -38.15%, and revenue of $0.00, 0% as expectations.
How did the market react to AN2 Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -4.24%, changed from $1.18 before the earnings release to $1.13 the day after.
When is AN2 Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 16. März 2026.
What are the forecasts for AN2 Therapeutics, Inc. Common Stock's next earnings report?
Based on 3
analysts, AN2 Therapeutics, Inc. Common Stock is expected to report EPS of -$0.24 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung